Federated Hermes
IMNM icon

Federated Hermes’s Immunome IMNM Stock Holding History

Federated Hermes’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01M Buy
+142,097
New +$3.04M ﹤0.01% 940
2024
Q2 		– Sell
-335
Closed -$8.27K – 2083
2024
Q1 		$8.27K Buy
335
+248
+285% +$5.03K ﹤0.01% 1796
2023
Q4 		$931 Buy
+87
New +$723 ﹤0.01% 1977

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Federated Hermes's IMNM Position: Q2 2026 in Review

Federated Hermes opened a new position in Immunome (IMNM) in Q2 2026: 142,097 shares worth $3.01M. The stake represents ﹤0.01% of the portfolio and ranks #940 among its holdings. This is a return to the name: Federated Hermes previously reported a position in IMNM as recently as Q1 2024.

Federated Hermes first reported a position in IMNM in Q4 2023 and has held it in 3 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Federated Hermes held 142,097 shares of Immunome worth $3.01M as of Q2 2026.
  • Immunome was a new Federated Hermes position in Q2 2026.
  • Immunome made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #940 holding.
  • Federated Hermes first reported a position in Immunome in Q4 2023 and has held it in 3 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.